期刊文献+

钆塞酸二钠增强MRI在肝脏结节性病变中的诊断价值 被引量:8

The value of Gd- EOB- DTPA in diagnosing hepatic nodules with MRI
暂未订购
导出
摘要 目的探讨钆塞酸二钠增强MRI检查在肝脏结节性病变中的诊断价值。方法疑似为肝脏结节性病变的50例患者,所有患者依次行MRI平扫、钆塞酸二钠动态增强扫描及延迟肝细胞特异期扫描。结果 50例患者共发现局灶性结节73枚。病理或临床诊断肝细胞肝癌(HCC)25例、肝脏转移瘤7例,再生结节(RN)5例,退变结节(DN)6例,肝血管瘤6例,肝脏局灶性结节性增生(FNH)2例,肝腺瘤1例。钆塞酸二钠增强MRI共诊断HCC 24例,肝脏转移瘤7例,RN 5例,DN 6例,肝血管瘤6例,FNH 2例,肝腺瘤1例,总体符合率98.1%。钆塞酸二钠增强MRI动脉期、门脉期和平衡期所有病灶符合应用常规含钆(Gd)剂时的强化表现和特征,延迟20 min肝细胞特异期扫描时,大部分恶性结节呈现低信号,仅1例肝细胞肝癌呈稍高信号,大部分良性结节呈高信号,但肝血管瘤呈低信号。结论采用钆塞酸二钠行MRI动态增强扫描对肝脏结节性病变的诊断有较好的诊断价值,尤其是钆塞酸二钠动态增强扫描与肝细胞特异期扫描联合应用,可以提供病变形态、血供、细胞来源及功能等更多相关信息,从而提高诊断准确性。 Objective To discuss the value of Gd-EOB-DTPA-enhanced MRI in diagnosis of nodular pathologic changes of liver. Methods In 50 patients suspected of nodular pathologic changes of liver,the MRI plain scanning,dynamic Gd-EOB-DTPA-enhanced MRI and delayed specificity scanning of hepatic cells were performed. Results 73 focal nodular hyperplasia cases were found on the 50 patients,including 25 cases of pathological or clinical diagnosis of HCC,7 cases of liver metastases,5 cases of RN,6 cases of DN,6 cases of hepatic hemangioma,two cases of FNH and 1 case of hepatic adenomas. Through the Gd-EOB-DTPA-enhanced MRI, 24 cases of HCC,7 cases of liver metastases,5 cases of RN,6 cases of DN,6 cases of hepatic hemangioma,two cases of FNH and one case of hepatic adenomas were found,achieving the overall coincidence rate of 98. 1%. In the arterial phase,portal phase and phase bal?ance,all lesions in the Gd-EOB-DTPA-enhanced MRI were in line with the performance and features of using the conventional gado?linium ( Gd) -contained agent. When the specificity scanning of hepatic cells delayed 20 minutes, most of the malignant nodules ap?peared low signal,but a case of hepatocellular carcinoma showed a slightly higher signal. In addition,most benign nodules showed high signal,and hepatic hemangioma cases showed low signal. Conclusion The dynamic Gd-EOB-DTPA enhanced MRI is meaningful for the diagnosis of nodular pathologic changes of liver. Especially,joint usage of dynamic Gd-EOB-DTPA-enhanced MRI and the liver parenchyma scanning can provide the information about lesion type,blood supply,and cell source and so on,thereby increasing diagnostic accuracy.
出处 《宁夏医学杂志》 CAS 2015年第1期55-57,I0001,共4页 Ningxia Medical Journal
基金 宁夏银川市科技发展项目(2012249)
关键词 钆塞酸二钠 磁共振成像 肝脏结节性病变 Gd-EOB-DTPA Magnetic resonance imaging Nodular pathologic changes of liver
  • 相关文献

参考文献7

  • 1Vasanawala SS.MRI of the liver-how to do it[J].Pediatr Radiol,2010,40(4):431-437.
  • 2Kanematsu M,Kondo H,Goshima S,et al.Magnetic resonance imaging of hepatocelluar carcinoma[J].Oncology,2008,75(Suppl l):65-71.
  • 3Balci NC,Semelka RC.Contrast agents for MR imaging of the liver[J].Radiol Clin North Am,2005,43(5):887-898.
  • 4Cristoph J,Karin A,Herrmann,et a1.MR imaging in pa tients with suspected liver metastases:value of liver specificcontrast agent GdEOB-DTPA[J].Magn Reson Med Ci,2007,6:43-52.
  • 5程伟中,曾蒙苏.新型多功能磁共振对比剂Gd-EOB-DTPA在肝胆系统病变中的应用[J].临床放射学杂志,2005,24(12):1107-1110. 被引量:15
  • 6Lee NK,Kim S,Kim GH,et al.Significance of the“delayedhyperintense portal vein sign”in the hepatobiliary phase MRI obtained with Gd-EOB-DTPA[J].J Magn Reson Imaging,2012,36(3):678-685.
  • 7Van Kessel CS,Veldhuis WB,Van Den Bosch MA,et al.MR liver imaging with Gd-EOB-DTPA:a delay time of 10 minutes is sufficient for lesion characterisation[J].Eur Radiol,2012,22(10):2153-2160.

二级参考文献23

  • 1Lim KO, Stark DD, Leese PT,et al. Hepatobiliary MRI: first human experience with MnDPDP. Radiology, 1991, 178:79.
  • 2Witzleben CL, Pitlick P, Bergmeyer J,et al. Acute manganese overload: a new experiental model of intrahepatic cholestasis. Am J Pathol, 1968, 55:409.
  • 3Hamm B, Kirchin M, Pirovano G,et al. Clinical utility and safety of multihance in MRI of liver cancer: results of multicenter studies in europe and the USA. J Comput Assist Tomogr, 1999, 53.
  • 4Schuhmann-Giampieri G, Schmitt-Willich H, Press WR,et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology, 1992, 183:56.
  • 5Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H,et al. A new lipophilic gadoliniumchelate as a tissue-specific contrast medium for MR imaging. Magn Reson Med, 1991, 22:233.
  • 6Hamm B, Staks T, Muhler A,et al. Phase Ⅰ chinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: Safety, pharmacokinetics, and MR imaging. Radiology, 1995, 195:785.
  • 7Reimer P, Rummeny EJ, Shamsi K,et al. Phase Ⅱ clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology, 1996, 199:177.
  • 8Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology, 2001, 218:27.
  • 9Moseley RH. Mechanisms of bile formation and cholestasis: clinical significance of recent experimental work. Am J Gastroenterol, 1986, 81:731.
  • 10Clement O, Mühler A, Vexler V,et al. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Invest, 1992, 27:612.

共引文献14

同被引文献30

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部